For people whose depression persists after multiple medications, newer treatments are delivering results on dramatically shorter timelines. Esketamine can begin working within hours, while a single 25 mg psilocybin session reduced depression scores by twice as much as a control dose in a 233-person trial and produced meaningful improvement in 37% of participants. Researchers are increasingly focusing on treatments that trigger lasting brain changes rather than requiring daily symptom management.